Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Sci Rep ; 7: 43921, 2017 03 07.
Article in English | MEDLINE | ID: mdl-28266622

ABSTRACT

The irreversibility of glomerulosclerotic changes depends on the degree of podocyte injury. We have previously demonstrated the endocytic translocation of podocin to the subcellular area in severely injured podocytes and found that this process is the primary disease trigger. Here we identified the protein sorting nexin 9 (SNX9) as a novel facilitator of podocin endocytosis in a yeast two-hybrid analysis. SNX9 is involved in clathrin-mediated endocytosis, actin rearrangement and vesicle transport regulation. Our results revealed and confirmed that SNX9 interacts with podocin exclusively through the Bin-Amphiphysin-Rvs (BAR) domain of SNX9. Immunofluorescence staining revealed the expression of SNX9 in response to podocyte adriamycin-induced injury both in vitro and in vivo. Finally, an analysis of human glomerular disease biopsy samples demonstrated strong SNX9 expression and co-localization with podocin in samples representative of severe podocyte injury, such as IgA nephropathy with poor prognosis, membranous nephropathy and focal segmental glomerulosclerosis. In conclusion, we identified SNX9 as a facilitator of podocin endocytosis in severe podocyte injury and demonstrated the expression of SNX9 in the podocytes of both nephropathy model mice and human patients with irreversible glomerular disease.


Subject(s)
Endocytosis , Intracellular Signaling Peptides and Proteins/metabolism , Membrane Proteins/metabolism , Podocytes/metabolism , Sorting Nexins/metabolism , Animals , Disease Models, Animal , Glomerulonephritis, IGA/pathology , Glomerulonephritis, Membranous/pathology , Glomerulosclerosis, Focal Segmental/pathology , Humans , Immunohistochemistry , Mice, Inbred BALB C , Protein Binding , Protein Interaction Mapping , Two-Hybrid System Techniques
2.
Nat Commun ; 5: 3296, 2014.
Article in English | MEDLINE | ID: mdl-24526233

ABSTRACT

Activation of Notch1 and Notch2 has been recently implicated in human glomerular diseases. Here we show that Notch2 prevents podocyte loss and nephrosis. Administration of a Notch2 agonistic monoclonal antibody ameliorates proteinuria and glomerulosclerosis in a mouse model of nephrosis and focal segmental glomerulosclerosis. In vitro, the specific knockdown of Notch2 increases apoptosis in damaged podocytes, while Notch2 agonistic antibodies enhance activation of Akt and protect damaged podocytes from apoptosis. Treatment with triciribine, an inhibitor of Akt pathway, abolishes the protective effect of the Notch2 agonistic antibody. We find a positive linear correlation between the number of podocytes expressing activated Notch2 and the number of residual podocytes in human nephrotic specimens. Hence, specific activation of Notch2 rescues damaged podocytes and activating Notch2 may represent a novel clinical strategy for the amelioration of nephrosis and glomerulosclerosis.


Subject(s)
Antibodies, Monoclonal/therapeutic use , Kidney Diseases/drug therapy , Receptor, Notch2/agonists , Animals , Antibodies, Monoclonal/pharmacology , Apoptosis/drug effects , CHO Cells , Cricetinae , Cricetulus , Doxorubicin , Drug Evaluation, Preclinical , Female , Humans , Kidney Diseases/chemically induced , Kidney Diseases/metabolism , Mice, Inbred BALB C , Mice, Inbred ICR , Mice, Nude , Podocytes/drug effects , Podocytes/metabolism , Proto-Oncogene Proteins c-akt/metabolism
3.
Clin J Am Soc Nephrol ; 7(9): 1385-93, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22700887

ABSTRACT

BACKGROUND AND OBJECTIVES: Podocalyxin (PCX) is present on the apical cell membrane of podocytes and is shed in urine from injured podocytes. Urinary podocalyxin (u-PCX) is associated with severity of active glomerular injury in patients with glomerular diseases. This study examined the relationship between number of urinary podocytes, levels of u-PCX, and glomerular injury in adults with IgA nephropathy (IgAN). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Urine samples voided in the morning on the day of biopsy were obtained from 51 patients with IgAN (18 men and 33 women; mean age, 31 years). All renal biopsy specimens were analyzed histologically. Pathologic variables of IgAN were analyzed per Shigematsu classification, the Oxford classification of IgAN, and the Clinical Guidelines of IgAN in Japan. Levels of u-PCX were measured by sandwich ELISA. RESULTS: Histologic analysis based on Shigematsu classification revealed a significant correlation between levels of u-PCX and severity of acute extracapillary abnormalities (r=0.72; P<0.001), but levels of urinary protein excretion did not correlate with acute glomerular abnormalities. Levels of urinary protein excretion in patients with segmental sclerosis (n=19) were higher than in patients without (n=22) (0.49 [interquartile range (IQR), 0.20-0.88] g/g creatinine versus 0.20 [IQR, 0.10-0.33] g/g creatinine; P<0.01). The number of urinary podocytes in patients with segmental sclerosis was higher than in patients without (1.05 [IQR, 0.41-1.67] per mg creatinine versus 0.28 [IQR, 0.10-0.66] per mg creatinine; P<0.01). CONCLUSIONS: Levels of u-PCX and the number of urinary podocytes are associated with histologic abnormalities in adults with IgAN.


Subject(s)
Glomerulonephritis, IGA/diagnosis , Glomerulosclerosis, Focal Segmental/diagnosis , Podocytes/metabolism , Podocytes/pathology , Sialoglycoproteins/urine , Adult , Biomarkers/blood , Biomarkers/urine , Biopsy , Creatinine/blood , Creatinine/urine , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Glomerulonephritis, IGA/blood , Glomerulonephritis, IGA/complications , Glomerulonephritis, IGA/pathology , Glomerulonephritis, IGA/urine , Glomerulosclerosis, Focal Segmental/etiology , Glomerulosclerosis, Focal Segmental/pathology , Glomerulosclerosis, Focal Segmental/urine , Humans , Japan , Male , Predictive Value of Tests , Proteinuria/diagnosis , Proteinuria/etiology , Proteinuria/urine , Sensitivity and Specificity , Severity of Illness Index , Urine/cytology , Young Adult
4.
Am J Nephrol ; 33(6): 537-49, 2011.
Article in English | MEDLINE | ID: mdl-21606645

ABSTRACT

BACKGROUND: Adriamycin (ADR) nephrosis in mice has been extensively studied and has enabled a greater understanding of the processes underlying the progression of renal injury. Dendrin is a novel component of the slit diaphragm with proapoptotic signaling properties, and it accumulates in the podocyte nucleus in response to glomerular injury in mice. The present study re-evaluated chronic progressive nephropathy in ADR mice and the localization of dendrin in mice and in human glomerulopathy. METHODS: To investigate the localization of dendrin, a mouse model of nephrosis and glomerulosclerosis was used, in which ADR was injected once. WT-1-positive cells and apoptotic cells were counted in vivo and in vitro. To check the expression of dendrin in ADR mice, immunostaining and Western blot were performed. A survey of dendrin staining was performed on human kidney biopsy specimens. RESULTS: The injection of ADR induced proteinuria, podocyte loss and glomerulosclerosis. It also caused the relocation of dendrin from the slit diaphragm to the podocyte nucleus. We demonstrated the location of dendrin to podocyte nuclei in several cases of human glomerulopathy. The mean occurrence of dendrin-positive nucleus per glomerulus increased in several cases of human glomerulopathy. CONCLUSIONS: These findings suggest that the relocation of dendrin to the podocyte nuclei is useful as a novel marker of podocyte injury in human glomerulopathy.


Subject(s)
Glomerulosclerosis, Focal Segmental/metabolism , Nephrosis/metabolism , Nerve Tissue Proteins/metabolism , Podocytes/metabolism , Animals , Antibiotics, Antineoplastic , Apoptosis , Cell Nucleus/metabolism , Cells, Cultured , Doxorubicin , Female , Glomerular Basement Membrane/pathology , Glomerulosclerosis, Focal Segmental/pathology , Humans , Mice , Mice, Inbred BALB C , Nephrosis/chemically induced , Nephrosis/pathology , Podocytes/pathology , Proteinuria/chemically induced , Proteinuria/metabolism , Proteinuria/pathology , Rats
SELECTION OF CITATIONS
SEARCH DETAIL
...